A detailed history of Pathstone Holdings, LLC transactions in Novartis Ag stock. As of the latest transaction made, Pathstone Holdings, LLC holds 103,150 shares of NVS stock, worth $10.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
103,150
Previous 135,273 23.75%
Holding current value
$10.1 Million
Previous $14.4 Million 17.62%
% of portfolio
0.05%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$106.13 - $120.89 $3.41 Million - $3.88 Million
-32,123 Reduced 23.75%
103,150 $11.9 Million
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $540,516 - $626,933
-5,839 Reduced 4.14%
135,273 $14.4 Million
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $4.15 Million - $4.72 Million
43,549 Added 44.64%
141,112 $13.6 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $9 Million - $9.91 Million
97,563 New
97,563 $9.85 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.